Filing Details

Accession Number:
0001447362-22-000111
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-06-13 19:00:10
Reporting Period:
2022-01-04
Accepted Time:
2022-06-13 19:00:10
Original Submission Date:
2022-01-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236397 Daniel Bradbury C/O Castle Biosciences, Inc.
505 S. Friendswood Drive, Suite 401
Friendswood TX 77546
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-04 7,303 $43.92 238,690 No 4 S Indirect By LLC
Common Stock Disposition 2022-01-04 4,375 $43.02 130,905 No 4 S Indirect By Daniel Bradbury Irrecovable Descendant's Trust
Common Stock Disposition 2022-01-04 4,375 $43.46 130,930 No 4 S Indirect By Annette Bradbury Irrecovable Descendant's Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LLC
No 4 S Indirect By Daniel Bradbury Irrecovable Descendant's Trust
No 4 S Indirect By Annette Bradbury Irrecovable Descendant's Trust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on November 30, 2021.
  2. This transaction was executed in multiple trades at prices ranging from $43.750 to $44.305, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
  4. This transaction was executed in multiple trades at prices ranging from $42.695 to $43.300, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
  6. This transaction was executed in multiple trades at prices ranging from $43.300 to $43.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.